Your browser doesn't support javascript.
loading
Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma.
Tiedemann, Rochelle L; Hlady, Ryan A; Hanavan, Paul D; Lake, Douglas F; Tibes, Raoul; Lee, Jeong-Heon; Choi, Jeong-Hyeon; Ho, Thai H; Robertson, Keith D.
Affiliation
  • Tiedemann RL; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, MI, USA.
  • Hlady RA; Department of Molecular Pharmacology and Experimental Therapeutics and Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, MN, USA.
  • Hanavan PD; School of Life Sciences, Mayo Clinic Collaborative Research Building, Arizona State University, Scottsdale, AZ, USA.
  • Lake DF; School of Life Sciences, Mayo Clinic Collaborative Research Building, Arizona State University, Scottsdale, AZ, USA.
  • Tibes R; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Lee JH; Epigenomics Translational Program, Center for Individualized Medicine, Rochester, MN, USA.
  • Choi JH; Epigenomics Translational Program, Center for Individualized Medicine, Rochester, MN, USA.
  • Ho TH; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Robertson KD; Department of Biostatistics, Georgia Regents University, Augusta, GA, USA.
Oncotarget ; 7(2): 1927-46, 2016 Jan 12.
Article in En | MEDLINE | ID: mdl-26646321

Full text: 1 Database: MEDLINE Main subject: Histones / Carcinoma, Renal Cell / Gene Expression Regulation, Neoplastic / Histone-Lysine N-Methyltransferase / DNA Methylation / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Histones / Carcinoma, Renal Cell / Gene Expression Regulation, Neoplastic / Histone-Lysine N-Methyltransferase / DNA Methylation / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Year: 2016 Type: Article